<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Spertini, Francois</author>
      <author>Audran, Regine</author>
      <author>Chakour, Reza</author>
      <author>Karoui, Olfa</author>
      <author>Steiner-Monard, Viviane</author>
      <author>Thierry, Anne-Christine</author>
      <author>Mayor, Carole E.</author>
      <author>Rettby, Nils</author>
      <author>Jaton, Katia</author>
      <author>Vallotton, Laure</author>
      <author>Lazor-Blanchet, Catherine</author>
      <author>Doce, Juana</author>
      <author>Puentes, Eugenia</author>
      <author>Marinova, Dessislava</author>
      <author>Aguilo, Nacho</author>
      <author>Martin, Carlos</author>
    </authors>
  </contributors>
  <titles>
    <title>Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial</title>
    <secondary-title>The Lancet. Respir. med.</secondary-title>
  </titles>
  <doi>10.1016/S2213-2600(15)00435-X</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2015</year>
    <pub-dates>
      <date>2015</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>